Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2016-12-06
Target enrollment:
Participant gender:
Summary
This study will evaluate the long-term safety of bimatoprost 0.01% ophthalmic solution
compared with bimatoprost 0.03% ophthalmic solution in patients with glaucoma or ocular
hypertension.